Incannex Healthcare Limited
IXHL | NASDAQ
$2.56
+$0.04 (+1.59%)
Nov 2, 2026, 12:26 PM ET · Market open
Market Data
Market Cap $30.68M
Enterprise Value $-37.46M
Beta 2.82
Average Volume 194.89K
Shares Outstanding (Diluted) 12.32M
Shares Change YoY 132.8%
Institutional Ownership 3.90%
Exchange NASDAQ
ISIN US45333F2083
Price Performance
Price Change 1M -20.3%
Price Change 3M -12.6%
Price Change 6M -44.6%
Price Change YTD -76.2%
Price Change 1Y -75.9%
Price Change 3Y -98.1%
Price Change 5Y N/A
1M CAGR (ann.) -30.8%
1Y CAGR (ann.) -75.5%
5Y CAGR (ann.) N/A
All-Time CAGR -75.5%
Valuation
PE Ratio -2.25
Forward PE 32.44
PEG Ratio -0.07
Forward PEG -0.07
PS Ratio N/A
Forward PS 0.80
PB Ratio 0.45
P/FCF Ratio -3.63
P/Adj. FCF Ratio -2.13
P/OCF Ratio -3.76
EV/Sales N/A
EV/EBIT 1.63
EV/EBITDA 1.64
EV/FCF 4.52
Earnings Yield -44.4%
FCF Yield -27.5%
Adj. FCF Yield -46.9%
Financial Health
Net Cash $67.62M
Total Debt $96K
Cash & Short-Term Investments $67.71M
Total Assets $72.98M
Current Ratio 48.81
Quick Ratio 48.81
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.01
OCF / Debt -85.74
Interest Coverage 0.00
Altman Z-Score -0.03
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -70.3%
Returns
Return on Assets -17.6%
Return on Equity -18.3%
Return on Invested Capital -22.6%
Return on Capital Employed -22.6%
Return on Tangible Assets -17.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -150.0%
Revenue CAGR 5Y -65.8%
Revenue CAGR 10Y -18.4%
EPS CAGR 3Y -21.3%
EPS CAGR 5Y -10.0%
EPS CAGR 10Y -11.9%
FCF CAGR 3Y -13.7%
FCF CAGR 5Y -30.9%
FCF CAGR 10Y -18.3%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y -26.2%
Revenue Growth Next 3Y N/A
Earnings Date Nov 13, 2026
EPS Estimate (next Q) -$0.66
EPS Growth Est (next Q) 10.0%
Revenue Est (next Q) $10M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-8.23M
Free Cash Flow $-8.3M
Adj. Free Cash Flow $-14.13M
FCF Per Share -$0.67
OCF Per Share -$0.67
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-23.03M
EBITDA $-22.79M
Net Income $-19.3M
EPS (Diluted) -$1.12
Revenue / Employee N/A
Profit / Employee $-1.61M
Employees 12
Add to Watchlist
Select watchlists to add or remove IXHL